vs
BALCHEM CORP(BCPC)与Madison Square Garden Sports Corp.(MSGS)财务数据对比。点击上方公司名可切换其他公司
Madison Square Garden Sports Corp.的季度营收约是BALCHEM CORP的1.5倍($403.4M vs $263.6M),BALCHEM CORP净利率更高(14.9% vs 2.0%,领先12.8%),Madison Square Garden Sports Corp.同比增速更快(12.8% vs 9.8%),过去两年BALCHEM CORP的营收复合增速更高(4.9% vs -3.1%)
Balchem Corp是一家全球特种化学品与营养原料供应商,核心业务覆盖人类营养、动物保健、制药、工业应用四大领域,为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
麦迪逊广场花园体育公司是总部位于美国纽约市的专业体育控股企业,深耕职业体育俱乐部运营、体育IP开发管理等核心业务,在北美体育产业领域拥有深厚的行业积累与较高的市场知名度。
BCPC vs MSGS — 直观对比
营收规模更大
MSGS
是对方的1.5倍
$263.6M
营收增速更快
MSGS
高出2.9%
9.8%
净利率更高
BCPC
高出12.8%
2.0%
两年增速更快
BCPC
近两年复合增速
-3.1%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $263.6M | $403.4M |
| 净利润 | $39.2M | $8.2M |
| 毛利率 | 35.6% | — |
| 营业利润率 | 19.8% | 5.5% |
| 净利率 | 14.9% | 2.0% |
| 营收同比 | 9.8% | 12.8% |
| 净利润同比 | 16.8% | 641.9% |
| 每股收益(稀释后) | $1.21 | $0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BCPC
MSGS
| Q4 25 | $263.6M | $403.4M | ||
| Q3 25 | $267.6M | $39.5M | ||
| Q2 25 | $255.5M | $204.0M | ||
| Q1 25 | $250.5M | $424.2M | ||
| Q4 24 | $240.0M | $357.8M | ||
| Q3 24 | $239.9M | $53.3M | ||
| Q2 24 | $234.1M | $227.3M | ||
| Q1 24 | $239.7M | $430.0M |
净利润
BCPC
MSGS
| Q4 25 | $39.2M | $8.2M | ||
| Q3 25 | $40.3M | $-8.8M | ||
| Q2 25 | $38.3M | $-1.8M | ||
| Q1 25 | $37.1M | $-14.2M | ||
| Q4 24 | $33.6M | $1.1M | ||
| Q3 24 | $33.8M | $-7.5M | ||
| Q2 24 | $32.1M | $25.5M | ||
| Q1 24 | $29.0M | $37.9M |
毛利率
BCPC
MSGS
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
营业利润率
BCPC
MSGS
| Q4 25 | 19.8% | 5.5% | ||
| Q3 25 | 20.4% | -69.5% | ||
| Q2 25 | 20.1% | -11.1% | ||
| Q1 25 | 20.4% | 7.6% | ||
| Q4 24 | 19.8% | 3.7% | ||
| Q3 24 | 20.0% | -15.5% | ||
| Q2 24 | 19.6% | 23.0% | ||
| Q1 24 | 17.4% | 18.5% |
净利率
BCPC
MSGS
| Q4 25 | 14.9% | 2.0% | ||
| Q3 25 | 15.1% | -22.3% | ||
| Q2 25 | 15.0% | -0.9% | ||
| Q1 25 | 14.8% | -3.4% | ||
| Q4 24 | 14.0% | 0.3% | ||
| Q3 24 | 14.1% | -14.1% | ||
| Q2 24 | 13.7% | 11.2% | ||
| Q1 24 | 12.1% | 8.8% |
每股收益(稀释后)
BCPC
MSGS
| Q4 25 | $1.21 | $0.34 | ||
| Q3 25 | $1.24 | $-0.37 | ||
| Q2 25 | $1.17 | $-0.08 | ||
| Q1 25 | $1.13 | $-0.59 | ||
| Q4 24 | $1.03 | $0.05 | ||
| Q3 24 | $1.03 | $-0.31 | ||
| Q2 24 | $0.98 | $1.07 | ||
| Q1 24 | $0.89 | $1.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $81.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $-282.1M |
| 总资产 | $1.7B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BCPC
MSGS
| Q4 25 | $74.6M | $81.3M | ||
| Q3 25 | $65.1M | $48.6M | ||
| Q2 25 | $65.4M | $144.6M | ||
| Q1 25 | $49.9M | $96.5M | ||
| Q4 24 | $49.5M | $107.8M | ||
| Q3 24 | $73.7M | $52.3M | ||
| Q2 24 | $63.7M | $89.1M | ||
| Q1 24 | $60.3M | $40.0M |
股东权益
BCPC
MSGS
| Q4 25 | $1.3B | $-282.1M | ||
| Q3 25 | $1.3B | $-294.2M | ||
| Q2 25 | $1.3B | $-281.4M | ||
| Q1 25 | $1.2B | $-283.4M | ||
| Q4 24 | $1.1B | $-273.1M | ||
| Q3 24 | $1.2B | $-277.5M | ||
| Q2 24 | $1.1B | $-266.3M | ||
| Q1 24 | $1.1B | $-294.0M |
总资产
BCPC
MSGS
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | $1.7B | $1.5B | ||
| Q2 25 | $1.7B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.6B | $1.3B | ||
| Q1 24 | $1.6B | $1.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $67.3M | $32.4M |
| 自由现金流经营现金流 - 资本支出 | — | $31.6M |
| 自由现金流率自由现金流/营收 | — | 7.8% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | 1.72× | 3.94× |
| 过去12个月自由现金流最近4个季度 | — | $-480.0K |
8季度趋势,按日历期对齐
经营现金流
BCPC
MSGS
| Q4 25 | $67.3M | $32.4M | ||
| Q3 25 | $65.6M | $-85.0M | ||
| Q2 25 | $47.3M | $49.7M | ||
| Q1 25 | $36.5M | $6.3M | ||
| Q4 24 | $52.3M | $61.8M | ||
| Q3 24 | $51.3M | $-26.2M | ||
| Q2 24 | $45.0M | $108.4M | ||
| Q1 24 | $33.4M | $4.0M |
自由现金流
BCPC
MSGS
| Q4 25 | — | $31.6M | ||
| Q3 25 | — | $-85.3M | ||
| Q2 25 | — | $49.4M | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | — | $61.2M | ||
| Q3 24 | — | $-26.5M | ||
| Q2 24 | — | $108.0M | ||
| Q1 24 | — | $3.9M |
自由现金流率
BCPC
MSGS
| Q4 25 | — | 7.8% | ||
| Q3 25 | — | -216.3% | ||
| Q2 25 | — | 24.2% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | — | -49.7% | ||
| Q2 24 | — | 47.5% | ||
| Q1 24 | — | 0.9% |
资本支出强度
BCPC
MSGS
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
现金转化率
BCPC
MSGS
| Q4 25 | 1.72× | 3.94× | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | 55.61× | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | 4.25× | ||
| Q1 24 | 1.15× | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
MSGS
| Event Related | $167.2M | 41% |
| Media Rights | $122.3M | 30% |
| Sponsorship Signage And Suite Licenses | $98.5M | 24% |
| League Distribution | $15.4M | 4% |